Quick Takeaways
- 3i, LP filed SCHEDULE 13G for Processa Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (PCSA).
- Disclosed ownership: 4.9%.
- Date of event: 17 Jun 2025.
3i, LP - 17 Jun 2025 SCHEDULE 13G Report for Processa Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (PCSA)
- Filing Manager
- 3i, LP
- Reporting Manager
- 3i, LP
- Symbol
- PCSA
- Shares outstanding
- 34,325,388 shares
- Disclosed Ownership
- 1,681,944 shares
- Ownership
- 4.9%
- Form type
- SCHEDULE 13G
- Filing time
- 23 Jun 2025, 17:54:08 UTC
- Date of event
- 17 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"3i, LP disclosed 4.9% ownership in Processa Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (PCSA) on 17 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 23 Jun 2025, 17:54.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| 3i, LP | 4.9% | 1,681,944 | 0 | 1,681,944 | /s/ 3i, LP | Maier Joshua Tarlow, Manager of 3i Management LLC, General Partner of 3i, LP | |
| 3i Management LLC | 4.9% | 1,681,944 | 0 | 1,681,944 | /s/ 3i Management LLC | Maier Joshua Tarlow, Manager | |
| Maier Joshua Tarlow | 4.9% | 1,681,944 | 0 | 1,681,944 | /s/ Maier Joshua Tarlow | Maier Joshua Tarlow |